Mammalian MSC from selected species: Features and applications

Area of Science:

• Cellular Biology
• Regenerative Medicine
• Immunology

Background:

• Mesenchymal stromal/stem cells (MSC) are key candidates for cellular therapies.
• MSC are defined by specific surface markers (e.g., CD105+, CD73+, CD90+) and differentiation into osteogenic, adipogenic, and chondrogenic lineages.
• MSC possess immunomodulatory, anti-inflammatory, and proregenerative properties, largely due to migratory and secretory functions.

Purpose of the Study:

• To review the characteristics and therapeutic potential of MSC.
• To highlight the importance of understanding MSC behavior in specific disease environments.
• To emphasize the need for animal models to predict clinical efficacy.

Main Methods:

• Review of existing literature on MSC identification and function.
• Analysis of MSC marker expression and differentiation capabilities.
• Discussion of MSC migratory and secretory mechanisms.

Main Results:

• MSC from various sources and species share core characteristics but exhibit differences.
• MSC migrate to tissue lesions and secrete factors that promote self-repair.
• Clinical trials are underway, but the precise mode of MSC action in disease remains largely unknown.

Conclusions:

• MSC hold significant potential for human and veterinary medicine.
• Further research is essential to elucidate MSC responses in specific disease contexts.
• Pre-clinical studies in animal models are mandatory before widespread clinical application.